Scholars@Duke

Bevacizumab and everolimus in renal cancer: a rational way forward.

Publication ,  Journal Article
Stadler, WM; Phillips, G; George, DJ; Halabi, S; Small, E
Published in: J Clin Oncol
November 20, 2010
Published version (DOI) Link to item

Duke Scholars

Daniel James George
Author Daniel James George Medicine, Medical Oncology
Susan Halabi
Author Susan Halabi Biostatistics & Bioinformatics, Division of Biostatistics

Published In

J Clin Oncol

DOI

10.1200/JCO.2010.30.7934

EISSN

1527-7755

Publication Date

November 20, 2010

Volume

28

Issue

33

Start / End Page

e692 / e693

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factor A
  • Sirolimus
  • Oncology & Carcinogenesis
  • Kidney Neoplasms
  • Humans
  • Everolimus
  • Carcinoma, Renal Cell
  • Bevacizumab
  • Antineoplastic Combined Chemotherapy Protocols
  • Antibodies, Monoclonal, Humanized
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stadler, W. M., Phillips, G., George, D. J., Halabi, S., & Small, E. (2010). Bevacizumab and everolimus in renal cancer: a rational way forward. J Clin Oncol, 28(33), e692–e693. https://doi.org/10.1200/JCO.2010.30.7934
Stadler, Walter M., George Phillips, Daniel J. George, Susan Halabi, and Eric Small. “Bevacizumab and everolimus in renal cancer: a rational way forward.” J Clin Oncol 28, no. 33 (November 20, 2010): e692–93. https://doi.org/10.1200/JCO.2010.30.7934.
Stadler WM, Phillips G, George DJ, Halabi S, Small E. Bevacizumab and everolimus in renal cancer: a rational way forward. J Clin Oncol. 2010 Nov 20;28(33):e692–3.
Stadler, Walter M., et al. “Bevacizumab and everolimus in renal cancer: a rational way forward.” J Clin Oncol, vol. 28, no. 33, Nov. 2010, pp. e692–93. Pubmed, doi:10.1200/JCO.2010.30.7934.
Stadler WM, Phillips G, George DJ, Halabi S, Small E. Bevacizumab and everolimus in renal cancer: a rational way forward. J Clin Oncol. 2010 Nov 20;28(33):e692–e693.

Published In

J Clin Oncol

DOI

10.1200/JCO.2010.30.7934

EISSN

1527-7755

Publication Date

November 20, 2010

Volume

28

Issue

33

Start / End Page

e692 / e693

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factor A
  • Sirolimus
  • Oncology & Carcinogenesis
  • Kidney Neoplasms
  • Humans
  • Everolimus
  • Carcinoma, Renal Cell
  • Bevacizumab
  • Antineoplastic Combined Chemotherapy Protocols
  • Antibodies, Monoclonal, Humanized